Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection.
about
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits.Tissue penetration of antifungal agents.Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality.A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model.
P2860
Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacokinetics and pharmacod ...... y sight-threatening infection.
@ast
Pharmacokinetics and pharmacod ...... y sight-threatening infection.
@en
type
label
Pharmacokinetics and pharmacod ...... y sight-threatening infection.
@ast
Pharmacokinetics and pharmacod ...... y sight-threatening infection.
@en
prefLabel
Pharmacokinetics and pharmacod ...... y sight-threatening infection.
@ast
Pharmacokinetics and pharmacod ...... y sight-threatening infection.
@en
P2093
P2860
P50
P356
P1476
Pharmacokinetics and pharmacod ...... ly sight-threatening infection
@en
P2093
P2860
P304
P356
10.1128/AAC.01387-12
P407
P577
2012-10-31T00:00:00Z